Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Don T Nod Entertainment S.a.

Start price
Target price
Perf. (%)
€15.45
24.03.21
€16.80
24.03.22
-19.09%
25.03.22

Could be worthwhile Investment >10% per year
Capable Management
Razer Inc.

Start price
Target price
Perf. (%)
€0.25
24.03.21
€0.10
24.03.22
10.79%
25.03.22

Revenue growth >5% per year expected
Very capable Management
Very good company culture
Leading role in innovation
buy
Hexagon Purus As

Start price
Target price
Perf. (%)
€4.25
23.03.21
€5.00
23.03.22
-41.29%
10.12.21

Could be worthwhile Investment >10% per year
Fair valuation
Sustainability is very important
Stable Large shareholder and/or long term investor
Takung Art Co. Ltd.

Start price
Target price
Perf. (%)
€53.00
23.03.21
-
23.03.22
-46.79%
01.04.21

Probably not worthwhile Investment
overvalued
buy
Village Farms Internat. Inc.

Start price
Target price
Perf. (%)
€11.57
22.03.21
€16.00
22.03.22
-37.75%
08.11.21

Could be worthwhile Investment >10% per year
Fair valuation
Standard Investments for future growth
Innovative
Takung Art Co. Ltd.

Start price
Target price
Perf. (%)
€30.00
22.03.21
€18.00
22.03.22
11.33%
03.04.21

Good culture
Probably not worthwhile Investment
Below average Management
No uniques
buy
Odonate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.26
22.03.21
€5.00
22.03.22
-17.18%
03.04.21

Could be worthwhile Investment >10% per year
Innovative
Good culture
Few uniques
buy
Zacatecas Silver Corp.

Start price
Target price
Perf. (%)
€1.08
22.03.21
-
22.03.22
-44.44%
28.07.21

Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Undervalued
positive Cash Flow expected
buy
NAGA Group

Start price
Target price
Perf. (%)
€7.05
21.03.21
-
21.03.22
-16.60%
22.03.22

Revenue growth >5% per year expected
buy
Medley Management Inc.

Start price
Target price
Perf. (%)
€6.50
21.03.21
€10.00
21.03.22
-99.95%
22.03.22

Could be worthwhile Investment >10% per year
Lexinfintech Holdings Ltd.

Start price
Target price
Perf. (%)
€9.60
20.03.21
€5.00
20.03.22
-16.15%
03.04.21

Probably not worthwhile Investment
Acrinova Ab

Start price
Target price
Perf. (%)
€1.30
20.03.21
€0.000
20.03.22
-1.85%
03.04.21

Probably not worthwhile Investment
buy
Sea Ltd.

Start price
Target price
Perf. (%)
€182.00
20.03.21
€250.00
20.03.22
-38.46%
21.03.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
High Investments for future growth
Normal challenges to pay loans and raise capital
buy
STS Group AG

Start price
Target price
Perf. (%)
€7.40
19.03.21
€10.00
3.51%
24.03.21

Future proof or reliable business model
Could be very worthwhile Investment >20% year
Leading role in innovation
Revenue growth >5% per year expected
buy
STS Group AG

Start price
Target price
Perf. (%)
€6.90
15.03.21
€8.00
8.41%
18.03.21

Future proof or reliable business model
Could be very worthwhile Investment >20% year
Leading role in innovation
Revenue growth >5% per year expected
buy
Dataproces Group A/s

Start price
Target price
Perf. (%)
€1.28
12.03.21
€1.55
12.03.22
-37.19%
12.03.22

Could be worthwhile Investment >10% per year
Known brand
Future proof or reliable business model
Ether Capital Corp.

Start price
Target price
Perf. (%)
€2.06
11.03.21
-
11.03.22
0.00%
09.07.21

Revenue growth > 30% per year expected
EBIT decline > 20% expected
Probably not worthwhile Investment
Bilibili Inc.

Start price
Target price
Perf. (%)
€86.50
10.03.21
-
10.03.22
7.51%
20.03.21

buy
DMG Blockchain Solutions Inc.

Start price
Target price
Perf. (%)
€1.75
07.03.21
-
07.03.22
-77.66%
08.03.22

Differentiated customer and product portfolio
EBIT growth >5% per year expected
Good culture
Could be worthwhile Investment >10% per year
buy
Swiss Life Holding AG ADR

Start price
Target price
Perf. (%)
€20.79
03.03.21
€22.00
03.03.22
5.82%
02.04.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
Ocugen Inc.

Start price
Target price
Perf. (%)
€9.26
01.03.21
-
23.02.22
-72.34%
24.02.22

Could be worthwhile Investment >10% per year
buy
Xlife Sciences AG

Start price
Target price
Perf. (%)
€49.40
25.02.21
-
25.02.22
-12.15%
26.02.22

Zai Lab Ltd.

Start price
Target price
Perf. (%)
€130.00
23.02.21
€100.00
23.02.22
-43.08%
09.11.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
High valuation
Risky balance sheet
Ocugen Inc.

Start price
Target price
Perf. (%)
€6.88
23.02.21
-
23.02.22
34.59%
01.03.21

Could be worthwhile Investment >10% per year
buy
Yunhong Cti Ltd.

Start price
Target price
Perf. (%)
€2.74
23.02.21
€4.00
23.02.22
-32.12%
06.03.21

Could be worthwhile Investment >10% per year
Good culture
Fair valuation
Below average Management